Oncology Meeting Resources
- 05 Feb 2016,
The ESMO Preceptorship on Lung Cancer 2016 focused on enabling participants to learn about the evidence-base for lung cancer screening and novel diagnostic modalities, learn about the management of early stage NSCLC and use of adjuvant treatments, understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC, learn about the management of patients with actionable driver Mutations and novel targeted agents for advanced NSCLC, understand the role of immuno-checkpoint blockade for lung cancer and learn about novel immunotherapies, learn about treatment of NSCLC with oligometastatic disease, learn about the systemic treatment of mesothelioma and small-cell lung cancer and integrating palliative care in lung cancer treatment.
Webcasts from the ESMO Preceptorship on Lung Cancer 2016 are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.